Author Correction: Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2374-4677
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Author Correction: Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy ; volume:8 ; number:1 ; day:28 ; month:12 ; year:2022 ; pages:1-2 ; date:12.2022
npj Breast cancer ; 8, Heft 1 (28.12.2022), 1-2, 12.2022
- Urheber
-
Gharbi, Severine Isabelle
Pelletier, Laura A.
Espada, Alfonso
Gutiérrez, Jesus
Sanfeliciano, Sonia Maria Gutiérrez
Rauch, Charles T.
Ganado, Maria Patricia
Baquero, Carmen
Zapatero, Elisabet
Zhang, Aiping
Benach, Jordi
Russell, Anna-Maria
Cano, Leticia
Gomez, Sandra
Broughton, Howard
Pulliam, Nicholas
Perez, Carmen Maria
Torres, Raquel
Debets, Marjoke F.
de Dios, Alfonso
Puig, Oscar
Hilgers, Mark T.
Lallena, Maria Jose
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41523-022-00503-0
- URN
-
urn:nbn:de:101:1-2023030921253688822124
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gharbi, Severine Isabelle
- Pelletier, Laura A.
- Espada, Alfonso
- Gutiérrez, Jesus
- Sanfeliciano, Sonia Maria Gutiérrez
- Rauch, Charles T.
- Ganado, Maria Patricia
- Baquero, Carmen
- Zapatero, Elisabet
- Zhang, Aiping
- Benach, Jordi
- Russell, Anna-Maria
- Cano, Leticia
- Gomez, Sandra
- Broughton, Howard
- Pulliam, Nicholas
- Perez, Carmen Maria
- Torres, Raquel
- Debets, Marjoke F.
- de Dios, Alfonso
- Puig, Oscar
- Hilgers, Mark T.
- Lallena, Maria Jose
- SpringerLink (Online service)
Ähnliche Objekte (12)
The Drosophila Cyclin D-Cdk4 complex promotes cellular growth
Cyclin D1—Cdk4 regulates neuronal activity through phosphorylation of GABAA receptors
Efficient Wnt mediated intestinal hyperproliferation requires the cyclin D2-CDK4/6 complex
The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer
Regulation of CDK4
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary
The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix
LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer
Novel functions of aberrant cyclin D1/CDK4 activity in mantle cell lymphoma and consequences for proteasome inhibitor treatment
Anti-cancer activity of Psoralea fructus through the downregulation of cyclin D1 and CDK4 in human colorectal cancer cells
Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA
The Drosophila Cyclin D-Cdk4 complex promotes cellular growth
Cyclin D1—Cdk4 regulates neuronal activity through phosphorylation of GABAA receptors
Efficient Wnt mediated intestinal hyperproliferation requires the cyclin D2-CDK4/6 complex
The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer
Regulation of CDK4
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary
The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix
LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer
Novel functions of aberrant cyclin D1/CDK4 activity in mantle cell lymphoma and consequences for proteasome inhibitor treatment
Anti-cancer activity of Psoralea fructus through the downregulation of cyclin D1 and CDK4 in human colorectal cancer cells
Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA
The Drosophila Cyclin D-Cdk4 complex promotes cellular growth
Cyclin D1—Cdk4 regulates neuronal activity through phosphorylation of GABAA receptors
Efficient Wnt mediated intestinal hyperproliferation requires the cyclin D2-CDK4/6 complex
The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer
Regulation of CDK4
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary
The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix
LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer
Novel functions of aberrant cyclin D1/CDK4 activity in mantle cell lymphoma and consequences for proteasome inhibitor treatment
Anti-cancer activity of Psoralea fructus through the downregulation of cyclin D1 and CDK4 in human colorectal cancer cells